Sarah Roden

About the Author Sarah Roden

Sarah writes about stock market news for TipRanks. She graduated as member of Phi Beta Kappa from the University of Richmond in Richmond, Virginia.

Biotech Beat: Analysts Weigh In on Exelixis, Inc. (EXEL) and Mast Therapeutics Inc (MSTX)

There’s good news all around as Exelixis, Inc. (NASDAQ:EXEL) releases promising data in an attempt to expand the indication of one of its …

What to Watch at ASCO: Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG)

Analyst Geoff Porges from Leerink weighs in on pharmaceutical giants Gilead Sciences, Inc. (NASDAQ:GILD) and Celgene Corporation (NASDAQ:CELG) ahead of the American Society of Clinical …

Healthcare Roundup: Analysts Weigh In on ACADIA Pharmaceuticals Inc. (ACAD) and Celgene Corporation (CELG)

Healthcare analysts are optimistic on both ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and Celgene Corporation (NASDAQ:CELG) as ACADIA’s primary commercialized product received positive coverage and …

Biotech Roundup: Analysts Weigh In on Valeant Pharmaceuticals Intl Inc (VRX), Synergy Pharmaceuticals Inc (SGYP), and EXACT Sciences Corporation (EXAS)

Analysts weigh in on drug makers Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Synergy Pharmaceuticals Inc (NASDAQ:SGYP), and EXACT Sciences Corporation (NASDAQ:EXAS). While Valeant just hosted an investor …

Credit Suisse Weighs In Gilead Sciences, Inc. (GILD) and Celgene Corporation (CELG) Following Earnings

Credit Suisse analyst Alethia Young weighs in on biotech giants Gilead Sciences, Inc. (NASDAQ:GILD) and Celgene Corporation (NASDAQ:CELG) after both companies reported earnings.

The Good, the Bad and the Ugly: Morgan Stanley Weighs In on Apple Inc., AT&T Inc. and Twitter Inc

With earnings season in full swing, Morgan Stanley analysts explain why they are bullish on Apple Inc. (NASDAQ:AAPL), cautious on AT&T Inc.

Biotech Beat: Valeant Pharmaceuticals Intl Inc (VRX), Celgene Corporation (CELG), and Sarepta Therapeutics Inc (SRPT)

The ups and downs of biotech companies cease to abate as analysts weigh in on Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Celgene Corporation (NASDAQ:CELG), …

All Eyes on Apple Inc. (AAPL) F2Q16 Earnings This Evening: Analysts Weigh In

The most anticipated report of the entire earnings season will be released after today’s closing bell. Wells Fargo analyst Maynard Um and BMO Capital analyst Tim …

Analysts Chime In In Valeant Pharmaceuticals Intl Inc (VRX) And Perrigo Company plc (PRGO) After CEO Mixup

In an attempt to rectify a tumultuous year, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has poached a CEO from Perrigo Company plc (NYSE:PRGO). Following …

Biotech Spotlight: Analysts Weigh In on Celgene Corporation (CELG) and Relypsa Inc (RLYP)

Analysts weigh in on biotech companies Celgene Corporation (NASDAQ:CELG) and Relypsa Inc (NASDAQ:RLYP). While one analyst is bullish on Celgene ahead of earnings, …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts